Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007341
Chunk: 54

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 54
---
 |     | Under Delaware law, a stockholder may initiate a derivative                                                                                   
 action to enforce a right of a corporation if the corporation fails to enforce the right itself. The complaint must:                          
 ·     state                                                                                                                                   
 that the plaintiff was a stockholder at the time of the transaction of which the plaintiff complains or that the plaintiffs shares thereafter 
 devolved on the plaintiff by operation of law; and                                                                                            
 ·     allege                                                                                                                                  
 with particularity the efforts made by the plaintiff to obtain the action the plaintiff desires from the directors and the reasons for        
 the plaintiff’s failure to obtain the action; or                                                                                              
 ·     state                                                                                                                                   
 the reasons for not making the effort.                                                                                                        
 Additionally, the plaintiff must remain a stockholder through                                                                                 
 the duration of the derivative suit. The action will not be dismissed or compromised without the approval of the Delaware Court of Chancery.  |

| 42 |

<div align='center'>DESCRIPTION OF AMERICAN DEPOSITARY SHARES</div>

Our Depositary Shares are deposited pursuant
to the Second Amended and Restated Deposit Agreement dated December 18, 2023, among the Company, JPMorgan Chase Bank, N.A., as depositary,
and holders and beneficial owners of American Depositary Receipts, or the Deposit Agreement. The depositary registers and delivers the
Depositary Shares. Each Depositary Share represents ownership of 10,000 Ordinary Shares that we will deposit with the custodian, as agent
of the depositary, under the Deposit Agreement.

The depositary’s office is located
at 383 Madison Avenue, Floor 11, New York, NY 10179.

The Depositary Share-to-share ratio is subject
to amendment as provided in the form of American Depositary Receipt, or ADR (which may give rise to fees contemplated by the form of ADR).
In the future, each Depositary Share will also represent any securities, cash or other property deposited with the depositary but which
they have not distributed directly to you.

A beneficial owner is any person or entity
having a beneficial ownership interest in Depositary Shares. A beneficial owner need not be the holder of the ADR evidencing such Depositary
Share. If a beneficial owner is not an ADR holder, it must rely on the holder of the ADR(s) evidencing such Depositary Shares in order
to assert any rights or receive any benefits under the Deposit Agreement. A beneficial owner shall only be able to exercise any right
or receive any benefit under the